至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Spherical nucleic acids as an infectious disease vaccine platform

Proc Natl Acad Sci U S A. 2022-03; 
Michelle H Teplensky, Max E Distler, Caroline D Kusmierz, Michael Evangelopoulos, Haley Gula, Derek Elli, Anastasia Tomatsidou, Vlad Nicolaescu, Ian Gelarden, Anjana Yeldandi, Daniel Batlle, Dominique Missiakas, Chad A Mirkin
Products/Services Used Details Operation
Catalog Antibody … injection in C57BL/6 mice (n = 3 to 6 per group). RBD-specific binding antibodies were assessed by ELISA on mouse sera collected 2 wk postprime injection. … (MAB, GenScript, A02051) … Get A Quote

摘要

SignificanceUsing SARS-CoV-2 as a relevant case study for infectious disease, we investigate the structure-function relationships that dictate antiviral spherical nucleic acid (SNA) vaccine efficacy. We show that the SNA architecture can be rapidly employed to target COVID-19 through incorporation of the receptor-binding domain, and that the resulting vaccine potently activates human cells in vitro and mice in vivo. Furthermore, when challenged with a lethal viral infection, only mice treated with the SNA vaccine survived. Taken together, this work underscores the importance of rational vaccine design for infectious disease to yield vaccines that elicit more potent immune responses to effectively fight diseas... More

关键词

antiviral vaccines, infectious disease, rational vaccinology, spherical nucleic acids